Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Ravi, S. Khurana, J. Plumb, G. Booth, M. Catley, E. Smith, L. Healy, J. Vestbo, D. Singh (Slough, United Kingdom). Enhanced IL-6 and CCL3 activity in COPD. Eur Respir J 2012; 40: Suppl. 56, 791

Member's Comments

No comment yet.

Related content which might interest you: Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 Decreased T-bet expression and changes in levels of chemokines (IP-10, MIG, RANTES, MCP-1 and IL-8) in peripheral blood of adults with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 593s Year: 2006 Serum levels of IL-5, IL-6 and IL-8 in moderate and severe asthma clusters Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Levels of interleukins IL-4, IL-6, IL-8 and TNFa in sera of patients with tuberculosis before and during treatment Source: Eur Respir J 2002; 20: Suppl. 38, 556s Year: 2002 Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006 The upregulation of CD-11B expression on circulating neutrophils by CXCL8 and the involvement of CXCR1 in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 749s Year: 2006 Contribution of eotaxin (CCL11) to eosinophil chemotactic activity of asthmatic sputum Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004 Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD Source: Eur Respir J 2016; 47: 1093-1102 Year: 2016 TNF-a and IL-10 control macrophage expression of CXCL13, a prognostic biomarker of idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma Source: Eur Respir J 2003; 22: 310-316 Year: 2003 Proinflammatory cytokines in induced sputum and COPD phenotype Source: Annual Congress 2011 - COPD: human studies Year: 2011 Leptin stimulates CXCL2 and CXCL8 production in airway epithelial cells Source: Annual Congress 2009 - Lung cell biology and immunology Year: 2009 Serum levels of IL-10 and IL-12p40 in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 139s Year: 2007 Increased in vitro production of IP-10/CXCL10 and MIG/CXCL9 by alveolar macrophages in sarcoidosis and EAA but not in IPF Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 LPS-induced TLR4 expression and cytokine release is impaired in monocytes and T-lymphocytes of COPD patients Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008 Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 & CXCR2) gene expression in severe exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 377s Year: 2002 Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 and CXCR2) gene expression in severe exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003 Cytokine modulators as novel therapies for airway disease Source: Eur Respir J 2001; 18: 67S-77S Year: 2001